People: Pluristem Therapeutics Inc (PSTI.O)

PSTI.O on Consolidated Issue listed on NASDAQ Capital Market

2.95USD
24 Oct 2014
Price Change (% chg)

$0.01 (+0.34%)
Prev Close
$2.94
Open
$2.97
Day's High
$2.97
Day's Low
$2.88
Volume
44,282
Avg. Vol
136,413
52-wk High
$4.63
52-wk Low
$2.58

Search Stocks

Ben-Yoram, Israel 

Brief Biography

Mr. Israel Ben-Yoram is Independent Director of Pluristem Therapeutics, Inc. He has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel since 1985. In addition, since 1992, Mr. Ben-Yoram has been a shareholder and has served as the head director of Mor, Ben-Yoram Ltd., a private company in Israel in parallel to the operation of Mor, Ben-Yoram and Partners. This company provides management services, economic consulting services and other professional services to businesses. Furthermore, Mr. Ben-Yoram is the CEO of Eshed Dash Ltd. and Zonbit Ltd. During 2003-2004 Mr. Ben-Yoram served as a director of Brainstorm Cell Therapeutics Inc. (BCLI) and Smart Energy solutions, Inc. (SMGY), both of which were traded on the NASDAQ. Mr. Ben-Yoram received a B.A. in accounting from the University of Tel Aviv, an M.A. in Economics from the Hebrew University of Jerusalem, an LL.B. and an MBA from Tel Aviv University and an LL.M. from Bar Ilan University. In addition, Mr. Ben-Yoram is qualified in arbitration and in mediation.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable 2,861,339 --
Unexercisable 5,493,750 --
Exercised -- --
Name Fiscal Year Total

Zami Aberman

1,662,950

Yaky Yanay

1,124,280

Boaz Gur-Lavie

--

Doron Shorrer

--

Issac Braun

--

Mark Germain

--
As Of 29 Jun 2013
Search Stocks